Fair Value Calculator Fair Value Calculator
EN DE

M.K. Exim (India) Limited (MKEXIM) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹2.5B

MK M.K. Exim (India) Limited MKEXIM · BSE
Price₹60.99
Fair Value₹58.66
Upside-3.8%
Quality57/100
Watch M.K. Exim (India) Limited for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹33.73 – ₹105.39

Fair value as of: Jul 5, 2026

From 26 valuation models · updated today

Share price +14.7% over the past month.

Price vs Fair Value (12 months)

₹89.97 ₹40.43 Fair Value ₹58.66 Jul 2025 Jul 2026

12‑month range ₹40.43 – ₹89.97 · fair‑value band ₹33.73 – ₹105.39 · the ₹60.99 price screens above the ₹58.66 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

M.K. Exim (India) Limited (MKEXIM) currently trades at ₹60.99, while our model-based Fair Value estimate is ₹58.66 — implying the stock looks roughly 3.8% overvalued today. We read business quality at 57/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, M.K. Exim (India) Limited generated revenue of ₹973M at a net margin of 20.6%. Revenue declined 0.1% year over year. It earns a return on equity of 18.2%. Net debt stands at ₹2.2M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹33.73 (bear case) to ₹105.39 (bull case); at ₹60.99, the current price sits within that range. The share trades about 36% below its 52-week high and 53% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -47% fair-value upside — at -4%, MKEXIM screens cheaper than that median.

Key figures & financial health

Revenue (TTM) ₹973M
Revenue growth (YoY) -0.1%
Net margin 20.6%
Return on equity 18.2%
Free cash flow ₹49.5M FY2026
P/E ratio 12.3
More key figures
Operating margin 27.5%
EPS (TTM) ₹4.96
EPS growth (YoY) +88.6%
Net debt ₹2.2M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

About the company

M.K. Exim (India) Limited engages in the manufacture and sale of fabrics, readymade garments, and jewelry in India. It operates through Finish Fabrics, Garments & Plastic Material; and Cosmetics segments. The company provides polyester viscose and polyester cotton blended shirting and suiting products, pure wool suitings, and polyester wool blended suiting under the Cashmere Fabrics, French Elegance, Jhai Jhoray, Classic, Isiem, and Galaxy brands. In addition, the company supplies relief supplies; and distributes cosmetics under the Morrocanoil, John paul Mitchell systems, BCL Spa, K18 BIOMIMETIC HAIRSCIENCE, and ITS A 10 brand names. It exports its products. M.K. Exim (India) Limited was incorporated in 1992 and is based in Jaipur, India.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

M.K. Exim (India) Limited reported revenue of ₹973M in FY2026 versus ₹732M in FY2022, a compound +7.4%/yr. Reported net income was ₹200M in FY2026, compounding +10.7%/yr from FY2022.

Revenue +7.4%/yr
FY22 ₹732M
FY23 ₹1.0B
FY24 ₹924M
FY25 ₹927M
FY26 ₹973M
Net income +10.7%/yr
FY22 ₹133M
FY23 ₹166M
FY24 ₹154M
FY25 ₹180M
FY26 ₹200M

Is MKEXIM fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "M.K. Exim (India) Limited Fair Value". https://www.fairvalue-calculator.com/stock/MKEXIM

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG 2,590 MXN 108.66 MXN -96%
L'Oréal S.A LRLCF $450.56 $209.17 -54%
Unilever PLC UNLYF $59.34 $46.11 -22%
Colgate-Palmolive Company CPA €77.58 €35.72 -54%
Hindustan Unilever Limited HINDUNILVR ₹2,185 ₹1,000 -54%
Reckitt Benckiser Group RBGLY $12.32 $17.37 +41%
Henkel AG HENOY $20.11 $21.49 +7%
Kimberly-Clark Corporation KMBB34 R$509.49 R$335.39 -34%
Kenvue Inc KVUE $17.71 $9.38 -47%
Church & Dwight Co CHDC34 R$488.56 R$243.53 -50%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is M.K. Exim (India) Limited (MKEXIM) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹58.66 versus a price of ₹60.99 — about −4% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MKEXIM?
Our model-based fair value for M.K. Exim (India) Limited is ₹58.66 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹60.99.
What is the quality score of MKEXIM?
M.K. Exim (India) Limited has a Quality Score of 57/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of M.K. Exim (India) Limited (MKEXIM)?
M.K. Exim (India) Limited reported trailing-twelve-month revenue of about ₹973M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of MKEXIM?
The net profit margin of M.K. Exim (India) Limited is about 20.6%, meaning it keeps roughly 20.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.